Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | GAA | P10253 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | DHODH | Q02127 | 1/20 | 0.41 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.41 |
| ▸ | TUBB | P07437 | 1/20 | 0.41 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.41 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.41 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27585806 | 0.87 | LMNA (0.47) | ALDH1A1GAALMNAHPGDMAPT | |
| SCHEMBL9755721 | 0.87 | ALDH1A1 (0.50) | ALDH1A1GAALMNAHPGDMAPT | |
| SCHEMBL9755727 | 0.84 | MEN1 (0.58) | ALDH1A1GAALMNAHPGDMAPT | |
| SCHEMBL9755713 | 0.83 | ALDH1A1 (0.46) | ALDH1A1GAALMNAHPGDSMN1; SMN2 | |
| SCHEMBL14493233 | 0.82 | TSHR (0.50) | ALDH1A1LMNASMN1; SMN2TSHRTDP1 | |
| SCHEMBL28980626 | 0.81 | SMN1; SMN2 (0.49) | ALDH1A1GAALMNAHPGDMAPT | |
| SCHEMBL12588740 | 0.80 | ALDH1A1 (0.59) | ALDH1A1GAALMNAHPGDMAPT | |
| SCHEMBL9755706 | 0.79 | ALDH1A1 (0.42) | ALDH1A1LMNAHPGDSMN1; SMN2KMT2A | |
| SCHEMBL6024157 | 0.79 | ALDH1A1 (0.54) | ALDH1A1GAALMNAHPGDSMN1; SMN2 | |
| SCHEMBL16349247 | 0.79 | ALDH1A1 (0.55) | ALDH1A1GAALMNAHPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114334274-B | Silver nanowire film and preparation method thereof | 深圳市善柔科技有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-114334274-A | Silver nanowire film and preparation method thereof | 深圳市善柔科技有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-117338303-B | Temperature-control viscosity multichannel hydrogel electrode for intra-operative intracranial electroencephalogram monitoring | 华中科技大学 | 2024-03-26 | — | — | CN | disclosed |
| CN-114334274-B | Silver nanowire film and preparation method thereof | 深圳市善柔科技有限公司 | 2024-03-08 | — | — | CN | disclosed |
| CN-117338303-A | Temperature-control viscosity multichannel hydrogel electrode for intra-operative intracranial electroencephalogram monitoring | 华中科技大学 | 2024-01-05 | — | — | CN | disclosed |
| CN-114334274-A | Silver nanowire film and preparation method thereof | 深圳市善柔科技有限公司 | 2022-04-12 | — | — | CN | disclosed |
| US-8039532-B2 | Heterocyclic compound, ultraviolet absorbent and composition containing the same | FUJIFILM CORPORATION (JP) | 2011-10-18 | — | — | US | disclosed |
| US-20100210762-A1 | HETEROCYCLIC COMPOUND, ULTRAVIOLET ABSORBENT AND COMPOSITION CONTAINING THE SAME | FUJIFILM CORPORATION (JP) | 2010-08-19 | — | — | US | disclosed |
| US-20100130638-A1 | ULTRAVIOLET ABSORBENT COMPOSITION | FUJIFILM CORPORATION (JP) | 2010-05-27 | — | — | US | disclosed |
| US-20100025642-A1 | ULTRAVIOLET ABSORBENT COMPOSITION | FUJIFILM CORPORATION (JP) | 2010-02-04 | — | — | US | disclosed |
| US-20090240067-A1 | METHOD OF PRODUCING A BISBENZODITHIOL COMPOUND | FUJIFILM CORPORATION (JP) | 2009-09-24 | — | — | US | disclosed |
| WO-1991006533-A1 | NOVEL PROCESS FOR MANUFACTURING COMPOUNDS WITH VALUABLE PHARMACOLOGICAL PROPERTIES AND NEW INTERMEDIATE PRODUCTS FOR THE MANUFACTURE OF THESE COMPOUNDS | BOEHRINGER MANNHEIM GMBH (DE) | 1991-05-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100210762-A1 | HETEROCYCLIC COMPOUND, ULTRAVIOLET ABSORBENT AND COMPOSITION CONTAINING THE SAME | F12, F2, CYP24A1 | ALDH1A1 1492/4885GAA 4733/4885LMNA 2510/4885 |
| US-20090240067-A1 | METHOD OF PRODUCING A BISBENZODITHIOL COMPOUND | SQOR, NQO1, PBRM1 | ALDH1A1 739/4885GAA 3775/4885LMNA 1821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.